Matthew Harrison Analyst PerformanceManaging Director at Morgan StanleyMatthew Harrison is a stock analyst at Morgan Stanley focused in the healthcare sector, covering 41 publicly traded companies. Over the past year, Matthew Harrison has issued 57 stock ratings, including buy, hold, and sell recommendations. While full access to Matthew Harrison's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Harrison's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings246 Last 12 YearsBuy Recommendations50.42% 119 Buy RatingsCompanies Covered41 Unique Companies Ratings Distribution236RatingsDistribution of strong buy, buy, hold, and sell ratings by Matthew Harrison.RatingPercentageCount Strong Buy0.0%0 ratings Buy50.4%119 ratings Hold44.5%105 ratings Sell5.1%12 ratingsOut of 236 total stock ratings issued by Matthew Harrison at Morgan Stanley, the majority (50.4%) have been Buy recommendations, followed by 44.5% Hold and 5.1% Sell.Best & Worst CallsBest Call0000.0%MRNAAug 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%SRPTApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ78.0% of companies on NASDAQ32 companiesNYSE22.0% of companies on NYSE9 companiesMatthew Harrison, an analyst at Morgan Stanley, currently covers 41 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare39 companies95.1%Industrials1 company2.4%Communication Services1 company2.4%Matthew Harrison of Morgan Stanley specializes in stock coverage within the Healthcare sector, with additional focus on Industrials and Communication Services companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY31 companies75.6%PHARMACEUTICALS8 companies19.5%GROUND TRANSPORTATION1 company2.4%MEDIA1 company2.4% Matthew Harrison's Ratings History at Morgan Stanley Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGILDGilead Sciences10/7/2026Lower Price Target$147.75$163.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/7/2026Boost Price Target$747.03$779.00Equal Weight$0.0000.00% ROIRRyder System10/2/2026Lower Price Target$231.00$280.00Positive$0.0000.00% ROILEGNLegend Biotech9/4/2026Set Price Target$21.75$65.00$0.0000.00% ROIMRNAModerna8/19/2026Reiterated Rating$174.38Neutral$0.0000.00% ROIAVIRAtea Pharmaceuticals8/13/2026Boost Price Target$5.37$7.00Equal Weight$0.0000.00% ROILEGNLegend Biotech8/12/2026Boost Price Target$21.46$49.00Overweight$0.0000.00% ROIINSMInsmed8/7/2026Reiterated Rating$129.81$218.00Overweight$0.0000.00% ROIBMRNBioMarin Pharmaceutical8/7/2026Boost Price Target$63.04$124.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals7/31/2026Boost Price Target$753.48$758.00Equal Weight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BIIBBiogen7/30/2026Boost Price Target$207.07$231.00Equal Weight$0.0000.00% ROIGILDGilead Sciences7/27/2026Lower Price Target$131.59$165.00Overweight$0.0000.00% ROIRRyder System7/24/2026Boost Price Target$265.16$310.00Positive$0.0000.00% ROIDNLIDenali Therapeutics7/23/2026Boost Price Target$22.91$36.00Overweight$0.0000.00% ROIMRNAModerna7/8/2026Boost Price Target$76.32$39.00Equal Weight$0.0000.00% ROIREGNRegeneron Pharmaceuticals7/8/2026Lower Price Target$664.62$730.00Equal Weight$0.0000.00% ROIGILDGilead Sciences7/8/2026Lower Price Target$135.63$166.00Overweight$0.0000.00% ROIPHVSPharvaris6/25/2026Boost Price Target$33.29$46.00Overweight$0.0000.00% ROIARGXargenex6/24/2026Boost Price Target$853.40$1,180.00Overweight$0.0000.00% ROIBIIBBiogen6/18/2026Boost Price Target$198.67$224.00Equal Weight$0.0000.00% ROIDNLIDenali Therapeutics5/22/2026Lower Price Target$18.64$35.00Overweight$0.0000.00% ROIDNLIDenali Therapeutics5/14/2026Lower Price Target$19.28$40.00Overweight$0.0000.00% ROILEGNLegend Biotech5/13/2026Lower Price Target$28.27$48.00Overweight$0.0000.00% ROIGILDGilead Sciences5/8/2026Lower Price Target$131.33$168.00$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2026Lower Price Target$54.01$119.00Overweight$0.0000.00% ROIBIIBBiogen4/30/2026Boost Price Target$187.53$206.00Equal Weight$0.0000.00% ROIBIIBBiogen4/28/2026Boost Price Target$183.30$200.00Equal Weight$0.0000.00% ROIGILDGilead Sciences4/28/2026Boost Price Target$129.38$175.00Overweight$0.0000.00% ROIBIIBBiogen4/10/2026Boost Price Target$173.98$200.00Equal Weight$0.0000.00% ROIGILDGilead Sciences4/10/2026Boost Price Target$140.63$175.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/10/2026Boost Price Target$746.69$796.00Equal Weight$0.0000.00% ROIINSMInsmed3/30/2026Upgrade$145.30$212.00Overweight$0.0000.00% ROIDNLIDenali Therapeutics3/26/2026Boost Price Target$20.16$42.00Overweight$0.0000.00% ROILEGNLegend Biotech3/11/2026Lower Price Target$20.13$49.00Overweight$0.0000.00% ROIINSMInsmed2/20/2026Set Price Target$165.38$166.00$0.0000.00% ROIMRNAModerna2/16/2026Set Price Target$42.23$30.00$0.0000.00% ROIRRyder System2/13/2026Boost Price Target$208.01$250.00Positive$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$147.23$171.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/2/2026Boost Price Target$754.63$769.00Equal Weight$0.0000.00% ROIINSMInsmed1/30/2026Boost Price Target$156.73$162.00Equal Weight$0.0000.00% ROIThese gold assets are priced for $1,800 gold [it's over $4,000] (Ad)Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.See the junior gold assets majors may target nextGILDGilead Sciences1/13/2026Lower Price Target$122.43$150.00Overweight$0.0000.00% ROIDNLIDenali Therapeutics1/8/2026Reiterated Rating$16.95$40.00Overweight$0.0000.00% ROIIOBTIO Biotech1/8/2026Downgrade$0.63Underweight$0.0000.00% ROIMRNAModerna12/12/2025Lower Price Target$29.91$28.00Equal Weight$0.0000.00% ROILEGNLegend Biotech12/12/2025Lower Price Target$22.63$50.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals12/12/2025Boost Price Target$737.42$768.00Equal Weight$0.0000.00% ROIGILDGilead Sciences12/12/2025Boost Price Target$123.21$151.00Overweight$0.0000.00% ROIPHVSPharvaris12/4/2025Boost Price Target$29.36$41.00Overweight$0.0000.00% ROIARGXargenex12/4/2025Boost Price Target$922.82$1,110.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals12/3/2025Downgrade$742.00$767.00Equal Weight$0.0000.00% ROIPHVSPharvaris11/14/2025Boost Price Target$24.47$37.00Overweight$0.0000.00% ROIZNTLZentalis Pharmaceuticals11/12/2025Lower Price Target$1.34$4.00Equal Weight$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/28/2025Lower Price Target$52.67$98.00Overweight$0.0000.00% ROIBIIBBiogen10/10/2025Boost Price Target$147.72$149.00Equal Weight$0.0000.00% ROIVRTXVertex Pharmaceuticals10/10/2025Lower Price Target$412.64$438.00Equal Weight$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/10/2025Lower Price Target$567.36$756.00Overweight$0.0000.00% ROIMRNAModerna10/10/2025Boost Price Target$26.62$32.00Equal Weight$0.0000.00% ROIARGXargenex10/1/2025Boost Price Target$780.96$1,040.00Overweight$000.0000.00% ROIIOBTIO Biotech9/30/2025Downgrade$0.37Equal Weight$0.0000.00% ROIDNLIDenali Therapeutics8/18/2025Lower Price Target$14.81$30.00Overweight$00.0000.00% ROIINSMInsmed8/13/2025Reiterated Rating$122.00$126.00Equal Weight$000.0000.00% ROILEGNLegend Biotech8/12/2025Boost Price Target$36.24$83.00Overweight$00.0000.00% ROIIOBTIO Biotech8/12/2025Lower Price Target$1.05$4.00Overweight$0.0000.00% ROIVRTXVertex Pharmaceuticals8/5/2025Set Price Target$472.27$439.00Equal Weight$000.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Reiterated Rating$545.46$761.00Overweight$000.0000.00% ROIMRNAModerna8/1/2025Reiterated Rating$29.56$32.00Equal Weight$00.0000.00% ROIBIIBBiogen8/1/2025Lower Price Target$124.95$144.00Equal Weight$000.0000.00% ROIARGXargenex8/1/2025Boost Price Target$667.75$766.00Overweight$000.0000.00% ROISRPTSarepta Therapeutics7/29/2025Boost Price Target$13.86$20.00Equal Weight$00.0000.00% ROIBMRNBioMarin Pharmaceutical7/22/2025Lower Price Target$58.00$96.00Overweight$00.0000.00% ROIINSMInsmed7/17/2025Boost Price Target$104.59$108.00Overweight$000.0000.00% ROIRRyder System7/15/2025Initiated Coverage$175.19$215.00Positive$000.0000.00% ROILEGNLegend Biotech7/10/2025Reiterated Rating$39.16$81.00Overweight$00.0000.00% ROIREGNRegeneron Pharmaceuticals7/10/2025Lower Price Target$561.21$754.00Overweight$000.0000.00% ROIVRTXVertex Pharmaceuticals6/20/2025Lower Price Target$438.85$460.00Equal Weight$000.0000.00% ROISRPTSarepta Therapeutics6/16/2025Reiterated Rating$20.30$40.00Equal Weight$00.0000.00% ROIINSMInsmed6/11/2025Boost Price Target$94.94$102.00Overweight$00.0000.00% ROIREGNRegeneron Pharmaceuticals6/2/2025Lower Price Target$493.24$755.00Overweight$000.0000.00% ROISRPTSarepta Therapeutics5/7/2025Lower Price Target$46.75$113.00Overweight$00.0000.00% ROIVRTXVertex Pharmaceuticals5/6/2025Boost Price Target$436.06$464.00Equal Weight$000.0000.00% ROIGILDGilead Sciences4/25/2025Boost Price Target$103.65$135.00Overweight$000.0000.00% ROISRPTSarepta Therapeutics4/11/2025Lower Price Target$49.41$182.00Overweight$00.0000.00% ROIAVIRAtea Pharmaceuticals4/11/2025Lower Price Target$2.65$6.00Equal Weight$0.0000.00% ROIBIIBBiogen4/9/2025Lower Price Target$111.00$152.00Equal Weight$000.0000.00% ROIMRNAModerna4/9/2025Lower Price Target$24.62$32.00Equal Weight$00.0000.00% ROILEGNLegend Biotech3/17/2025Lower Price Target$38.25$80.00Overweight$00.0000.00% ROITNYATenaya Therapeutics3/12/2025Lower Price Target$0.54$5.00Overweight$0.0000.00% ROIGILDGilead Sciences3/11/2025Boost Price Target$117.21$130.00Overweight$000.0000.00% ROIDNLIDenali Therapeutics3/7/2025Initiated Coverage$16.47$33.00Overweight$00.0000.00% ROIBIIBBiogen2/13/2025Lower Price Target$136.88$157.00Equal Weight$000.0000.00% ROIOminous New Day in America (Get Ready for it) (Ad)A market forecaster with a 55-year track record - including calls on 1970s double-digit inflation, the 1980s S&L collapse and Black Monday crash, and the 2000s dot-com bust and Lehman Brothers collapse - says a major shift is coming to how Americans bank, work and insure themselves. The New York Times has credited him as the first to spot looming dangers, and he has testified before Congress on past financial crises.Watch his free video and learn how to prepare nowGILDGilead Sciences2/12/2025Boost Price Target$96.14$123.00Overweight$000.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Boost Price Target$469.97$459.00Equal Weight$000.0000.00% ROIINSMInsmed2/6/2025Boost Price Target$81.44$90.00Overweight$000.0000.00% ROICMCSAComcast1/31/2025Lower Price Target$33.77$55.00Buy$00.0000.00% ROIMRNAModerna1/15/2025Lower Price Target$35.00$38.00Equal Weight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
